Injectable Tramadol Dosing
For adults with normal hepatic and renal function, intravenous tramadol should be administered as 50 mg at hours 0,2, and 4, then every 4 hours thereafter, with a maximum daily dose of 400 mg; intramuscular administration is not recommended due to lack of pharmacokinetic advantage over IV route and increased pain at injection site. 1, 2
Adult Dosing Guidelines
Intravenous Administration
Standard IV Regimen:
- Initial dosing: 50 mg IV at hours 0,2, and 4
- Maintenance: 50 mg IV every 4 hours
- Maximum daily dose: 400 mg 2
This regimen achieves rapid initial peak concentration while maintaining steady-state levels comparable to oral tramadol 100 mg every 6 hours, but with lower exposure to the active metabolite M1 2.
Alternative IV Regimen (less preferred):
- 75 mg IV at hours 0,3, and 6, then every 6 hours
- Results in higher peak concentrations and greater fluctuation 2
Breakthrough Pain (PACU/Ward):
- 1-1.5 mg/kg IV, titrated to effect
- Repeat every 4-6 hours as needed 3
Critical Safety Considerations
Avoid bolus doses >50 mg: Two cases of life-threatening seizures occurred within 4 minutes of administering IV tramadol 150 mg as a single bolus, despite rigorous screening 4. When doses exceed 50 mg, administer either as repeated low-dose boluses (25-50 mg every 5-15 minutes) or via controlled infusion 4.
Intramuscular route is NOT recommended: IM injections are painful and provide no pharmacokinetic advantage over IV administration 1.
Special Populations
Elderly Patients (≥65 years)
- Start at low end of dosing range
- Patients >75 years: Use even greater caution with reduced doses 5, 6
- Consider starting at 12.5-25 mg every 4-6 hours 7
Renal Impairment
- Creatinine clearance <30 mL/min: Tramadol is contraindicated 6
- Lower doses required for moderate impairment
Hepatic Impairment
- Severe hepatic impairment (Child-Pugh Class C): Tramadol is contraindicated 6
- Lower doses for moderate impairment 5
Pediatric Dosing
FDA Restrictions
Tramadol is contraindicated in:
- Children <12 years of age
- Children <18 years undergoing tonsillectomy/adenoidectomy
- Adolescents 12-18 years who are obese or have conditions increasing respiratory risk (e.g., obstructive sleep apnea, severe lung disease) 8
When Appropriate (Ages ≥12 years, non-contraindicated patients)
- IV dose: 1-1.5 mg/kg every 4-6 hours 3
- Pharmacokinetic studies show children have 18% lower exposure than adults, and adolescents have 11% lower exposure 9
Maximum Daily Limits
- Adults with normal function: 400 mg/day for immediate-release formulations 5, 10
- Extended-release formulations: 300 mg/day 5
- Never exceed these limits - risk of seizures increases significantly with higher doses 5, 6
Critical Contraindications and Warnings
Absolute Contraindications
- Concurrent use with MAO inhibitors or within 14 days of discontinuation
- Severe renal impairment (CrCl <30 mL/min)
- Severe hepatic impairment
- Children <12 years
- Post-tonsillectomy/adenoidectomy in patients <18 years 8
Use with Extreme Caution or Avoid
Serotonin syndrome risk: Avoid or use with extreme caution in patients taking:
- SSRIs (selective serotonin reuptake inhibitors)
- SNRIs (serotonin-norepinephrine reuptake inhibitors)
- Tricyclic antidepressants
- Triptans
- Other serotonergic agents 5, 10
Seizure Risk Factors
- History of seizures
- High doses or rapid dose escalation
- Concurrent medications lowering seizure threshold
- Renal or hepatic dysfunction 5, 4
Important Clinical Pearls
Tramadol is approximately one-tenth as potent as morphine 5, 10, making it suitable only for moderate to moderately severe pain, not severe pain requiring strong opioids.
Metabolism variability: Tramadol's efficacy depends on CYP2D6 metabolism to its active metabolite M1. Poor metabolizers (5-10% of Caucasians) may experience reduced analgesia 5.
Limited evidence for cancer pain: A Cochrane review concluded tramadol is likely not as effective as morphine for cancer pain and has limited supporting evidence 5, 10.
Respiratory depression risk is lower than traditional opioids at recommended doses, but still present, particularly with rapid IV boluses or high doses 11, 4.
Discontinuation
Never abruptly discontinue - taper gradually to avoid withdrawal symptoms including anxiety, sweating, insomnia, rigors, pain, nausea, tremors, diarrhea, and hallucinations 6.